Mari Tienhaara
- LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer (2025)
- Embo molecular medicine
- DUSP6 inhibition overcomes neuregulin/HER3-driven therapy tolerance in HER2+ breast cancer (2024)
- Embo molecular medicine